These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27680512)

  • 1. Integrative transcriptomic meta-analysis of Parkinson's disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson's disease.
    Santiago JA; Littlefield AM; Potashkin JA
    Sci Rep; 2016 Sep; 6():34579. PubMed ID: 27680512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.
    Santiago JA; Potashkin JA
    PLoS One; 2015; 10(11):e0142582. PubMed ID: 26566043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.
    Santiago JA; Scherzer CR; Potashkin JA
    PLoS One; 2014; 9(10):e109042. PubMed ID: 25279756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes.
    Santiago JA; Potashkin JA
    PLoS One; 2013; 8(12):e83940. PubMed ID: 24376773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients.
    Swanson CR; Berlyand Y; Xie SX; Alcalay RN; Chahine LM; Chen-Plotkin AS
    Mov Disord; 2015 Oct; 30(12):1648-56. PubMed ID: 26207725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Variants Linked to the Prodromal Stage of Parkinson's Disease (PD) Patients.
    Badawy MT; Salama AA; Salama M
    Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.
    Simuni T; Caspell-Garcia C; Coffey C; Chahine LM; Lasch S; Oertel WH; Mayer G; Högl B; Postuma R; Videnovic A; Amara AW; Marek K;
    Mov Disord; 2015 Sep; 30(10):1371-81. PubMed ID: 26095202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodromal features for Parkinson's disease--baseline data from the TREND study.
    Gaenslen A; Wurster I; Brockmann K; Huber H; Godau J; Faust B; Lerche S; Eschweiler GW; Maetzler W; Berg D
    Eur J Neurol; 2014 May; 21(5):766-72. PubMed ID: 24612314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up.
    Abdi IY; Bartl M; Dakna M; Abdesselem H; Majbour N; Trenkwalder C; El-Agnaf O; Mollenhauer B
    Neurobiol Dis; 2023 Feb; 177():105997. PubMed ID: 36634823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
    Dalamaga M
    Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression.
    Dong MX; Feng X; Xu XM; Hu L; Liu Y; Jia SY; Li B; Chen W; Wei YD
    Front Mol Neurosci; 2018; 11():257. PubMed ID: 30233306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the transcriptomic signatures of Parkinson's disease and major depression using single-cell and bulk data.
    Christodoulou CC; Onisiforou A; Zanos P; Papanicolaou EZ
    Front Aging Neurosci; 2023; 15():1273855. PubMed ID: 38020762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's disease.
    Bartl M; Nilsson J; Dakna M; Weber S; Schade S; Xylaki M; Fernandes Gomes B; Ernst M; Muntean ML; Sixel-Döring F; Trenkwalder C; Zetterberg H; Brinkmalm A; Mollenhauer B
    NPJ Parkinsons Dis; 2024 May; 10(1):102. PubMed ID: 38760408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.
    Liepelt-Scarfone I; Gauss K; Maetzler W; Müller K; Bormann C; Fruhmann Berger M; Timmers M; Streffer J; Berg D
    Neuroepidemiology; 2013; 41(3-4):174-82. PubMed ID: 24051361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dementia is associated with insulin resistance in patients with Parkinson's disease.
    Bosco D; Plastino M; Cristiano D; Colica C; Ermio C; De Bartolo M; Mungari P; Fonte G; Consoli D; Consoli A; Fava A
    J Neurol Sci; 2012 Apr; 315(1-2):39-43. PubMed ID: 22265943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.
    Pagonabarraga J; Martinez-Horta S; Fernández de Bobadilla R; Pérez J; Ribosa-Nogué R; Marín J; Pascual-Sedano B; García C; Gironell A; Kulisevsky J
    Mov Disord; 2016 Jan; 31(1):45-52. PubMed ID: 26408291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson' Disease.
    Santiago JA; Potashkin JA
    Front Aging Neurosci; 2017; 9():73. PubMed ID: 28424608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin conditions in early Parkinson's disease.
    Dinesh D; Lee JS; Gao X; Palacios N
    Parkinsonism Relat Disord; 2021 Mar; 84():40-46. PubMed ID: 33549915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.